Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.77

-0.01 (-0.56%)

As of Sep 28, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,597.7% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $1.77

Current
$1.77

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

1,149.7%

Low target

Base Case

$30.05

+1,597.7%

Avg target

Bull Case

$38.96

+2,101.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-59.2% from high

52-Week Low

$1.53

+15.7% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%